UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Role for Th17 Cells in the Immunopathogenesis of Atopic Dermatitis?

Journal of investigative dermatology, 2008-11, Vol.128 (11), p.2569-2571

2008

Volltextzugriff (PDF)

Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, 2024-04

2024

Volltextzugriff (PDF)

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

Journal of investigative dermatology, 2009-06, Vol.129 (6), p.1339-1350

2009

Volltextzugriff (PDF)

The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans

PloS one, 2011-02, Vol.6 (2), p.e17160

2011

Volltextzugriff (PDF)

Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments

PloS one, 2017-08, Vol.12 (8), p.e0183415

2017

Volltextzugriff (PDF)

Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study

British journal of dermatology (1951), 2022-09, Vol.187 (3), p.428-430

2022

Volltextzugriff (PDF)

Clinical and Ultrasonographic Characterization of Hidradenitis Suppurativa in Female Patients: Impact of Early Recognition of the Disease

Life (Basel, Switzerland), 2023-07, Vol.13 (8), p.1630

2023

Volltextzugriff (PDF)

Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single Center study

The Journal of dermatological treatment, 2022-05, Vol.33 (4), p.1-1985

2022

Volltextzugriff (PDF)

Cutaneous hyperpigmentation induced by apremilast

International journal of dermatology, 2018-04, Vol.57 (4), p.473-474

2018

Volltextzugriff (PDF)

Intellectual Disability and Hidradenitis Suppurativa

Dermatology (Basel), 2021, Vol.237 (3), p.386-388

2021

Volltextzugriff (PDF)

Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study

Journal of the European Academy of Dermatology and Venereology, 2023-08, Vol.37 (8), p.e1075-e1077

2023

Volltextzugriff (PDF)

Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience

Life (Basel, Switzerland), 2024-03, Vol.14 (3), p.395

2024

Volltextzugriff (PDF)

Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy

Italian Journal of Dermatology and Venereology, 2023-12, Vol.158 (6)

2023

Volltextzugriff (PDF)

Insights into the Pathogenesis of HS and Therapeutical Approaches

Biomedicines, 2021-09, Vol.9 (9), p.1168

2021

Volltextzugriff (PDF)

Therapy of PsO in Special Subsets of Patients

Biomedicines, 2022-11, Vol.10 (11), p.2879

2022

Volltextzugriff (PDF)

Consistency of Bacterial Triggers in the Pathogenesis of Hidradenitis Suppurativa

Vaccines (Basel), 2023-01, Vol.11 (1), p.179

2023

Volltextzugriff (PDF)

Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic

Journal of clinical medicine, 2021-12, Vol.10 (24), p.5841

2021

Volltextzugriff (PDF)

Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits

Biomedicines, 2022-11, Vol.10 (11), p.2973

2022

Volltextzugriff (PDF)

Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity

Journal of the American Academy of Dermatology, 2013-12, Vol.69 (6), p.947-953

2013

Volltextzugriff (PDF)

The spectrum of dermatoscopic patterns in blue nevi

Journal of the American Academy of Dermatology, 2012-08, Vol.67 (2), p.199-205

2012

Volltextzugriff (PDF)

Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With Apremilast

Transplantation, 2023-01, Vol.107 (1), p.e39-e40

2023

Volltextzugriff (PDF)

Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review

Expert opinion on biological therapy, 2022-12, Vol.22 (12), p.1475-1487

2022

Volltextzugriff (PDF)

Anti-Interleukin-17s for successful management of pustular psoriasis

Cytokine (Philadelphia, Pa.), 2023-11, Vol.171, p.156353-156353, Article 156353

2023

Volltextzugriff (PDF)

Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa

Dermatologic therapy, 2020-11, Vol.33 (6), p.e14387-n/a

2020

Volltextzugriff (PDF)

Rationale for the Development of Speckled Hyperpigmentation in the Areas of Psoriatic Plaques after Treatment with Biologic Agents

Journal of investigative dermatology, 2015-01, Vol.135 (1), p.318-320

2015

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(169)

Publikationsform

Sprache

Englisch
(207)
Italienisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(7)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

A Role for Th17 Cells in the Immunopathogenesis of Atopic Dermatitis?

Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativa

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans

Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments

Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study

Clinical and Ultrasonographic Characterization of Hidradenitis Suppurativa in Female Patients: Impact of Early Recognition of the Disease

Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single Center study

Cutaneous hyperpigmentation induced by apremilast

Intellectual Disability and Hidradenitis Suppurativa

Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study

Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience

Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy

Insights into the Pathogenesis of HS and Therapeutical Approaches

Therapy of PsO in Special Subsets of Patients

Consistency of Bacterial Triggers in the Pathogenesis of Hidradenitis Suppurativa

Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic

Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits

Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity

The spectrum of dermatoscopic patterns in blue nevi

Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With Apremilast

Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review

Anti-Interleukin-17s for successful management of pustular psoriasis

Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa

Rationale for the Development of Speckled Hyperpigmentation in the Areas of Psoriatic Plaques after Treatment with Biologic Agents

Suchergebnisse filtern